Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia.
Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia.
复制标题
精神分裂症黑质的质子磁共振波谱。
DOI:
10.1016/j.schres.2013.04.036
复制
发表时间:
2013
影响因子:
4.5
通讯作者:
Lahti,AdrienneC
中科院分区:
文献类型:
--
作者:
Reid,MeredithA;Kraguljac,NinaV;Avsar,KathyB;White,DavidM;denHollander,JanA;Lahti,AdrienneC
BACKGROUNDConverging evidence in schizophrenia points to disruption of the dopamine and glutamate neurotransmitter systems in the pathophysiology of the disorder. Dopamine is produced in the substantia nigra, but few neuroimaging studies have specifically targeted this structure. In fact, no studies of the substantia nigra in schizophrenia have used proton magnetic resonance spectroscopy (MRS). We sought to demonstrate the feasibility of acquiring single-voxel MRS measurements at 3T from the substantia nigra and to determine which metabolites could be reliably quantified in schizophrenia patients and healthy controls.METHODSWe used a turbo spin echo sequence with magnetization transfer contrast to visualize the substantia nigra and single-voxel proton MRS to quantify levels of N-acetylaspartate, glutamate and glutamine (Glx), and choline in the left substantia nigra of 35 people with schizophrenia and 22 healthy controls.RESULTSWe obtained spectra from the substantia nigra and quantified neurometabolites in both groups. We found no differences in levels of N-acetylaspartate/creatine, Glx/creatine, or choline/creatine between the groups. We found a significant correlation between Glx/creatine and overall cognitive performance, measured with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), in controls but not patients, a difference that was statistically significant.CONCLUSIONSOur study demonstrates the feasibility of obtaining single-voxel MRS data from the substantia nigra in schizophrenia. Such measurements may prove useful in understanding the biochemistry underlying cellular function in a region implicated in the pathophysiology of schizophrenia.